First Patient Enrolled in Cynata’s MEND Clinical Trial

NEXT STORY
PDS Biotech to Host Company Conference Call Following Oral Presentation of PDS0101 Data at 2021 ASCO Annual Meeting
PREV STORY
BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combination with Checkpoint Inhibitors in SCLC at the American Society of Clinical Oncology (ASCO) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inventiva announces the decision by the investigator to reduce the number of patients in the ongoing Phase II trial evaluating lanifibranor in type 2 diabetes patients (T2DM) with Non-Alcoholic Fatty Liver Disease (NAFLD)

author_avatar
NASDAQ Market News

New Lactation Rooms Added to the ABOG Educational Foundation Test Center

author_avatar
NASDAQ Market News

Insights on the Nephrology Devices Global Market to 2025 – Impact of COVID-19 with Ansoff Analysis

author_avatar
NASDAQ Market News